To promote the high-quality development of Yangpu's life and health industry, the Sino-UK Life and Health Innovation Technology Exchange Conference, hosted by the Yangpu Investment Promotion Office and Huahao Consulting, was held at Green Hill recently.

As co-founder of P4 Precision Medicine Accelerator, Nathan McNally has been devoted to creating a tech ecosystem over the past 15 years. Through the ecosystem, P4 has raised more than 2 billion pounds in private investment for over 2,000 start-ups. "Currently, our incubation projects cover tumor immunotherapy, digital therapies, new drug development, in vitro diagnostic reagents, biomarkers and other fields, and we hope to find application scenarios in China for these innovations from leading universities and hospitals in the UK."

Like Nathan McNally, top life and health experts and scholars, research teams of universities, cross-border technology transfer institutions, industrial investment institutions and start-ups from the UK came with valuable projects in the hope of finding new opportunities in Yangpu.

The one-stop genetic testing platform, the handheld premature birth screening medical device project, the AI-based personalized cancer diagnosis and treatment project, and the single drop blood test product for breast cancer…Entrepreneurs introduced their latest research findings in the field of life and health respectively. With the combination of theoretical support and medical practice, some of these projects have been commercialized initially after incubation and application.

Harae Dx, a cancer diagnostics startup in Silicon Valley, is developing a rapid detection technology to diagnose breast cancer: with just a single drop of blood, the test results can come out in 15 minutes, and the project has just got 15 million yuan in funding. Bradley Morgan, an investment consultant in the life sciences sector and Chief Business Officer of Harae Dx, said that as a next step, he hoped to seek strategic cooperation with Chinese medical institutions, medical device manufacturers and other companies, to lay a foundation for the company's future development in China.

Yangpu has long leveraged its unique strengths - rich scientific and educational resources, concentration of medical institutions and active innovation & entrepreneurship, to promote the incubation, transformation and industrialization of technological achievements in medicine and healthcare under the principle of proximity. There are currently more than 200 life and health companies in Yangpu, of which nearly 50 are above the designated size, including industrial leaders like WeDoctor, Neptunus, Bidepharm, iNNOSTiC and YXJ, as well as functional platforms such as Shanghai High-end Medical Device Innovation Center and Shanghai Technology Exchange.

In recent years, Yangpu has attached great importance to the people's pursuit of life and health well-being, actively promoted the coordinated development of the healthcare cause and industry, and endeavored to create a system of coordinated innovation of governments, companies, universities, research institutes, financial institutions, technology service agencies and users. Now, Yangpu is in a crucial period of innovation and development, in which the life and health industry is one of the four key emerging fields in Yangpu.

Since the beginning of this year, Yangpu has established a "chain leader system" working mechanism for 12 segmented industrial chains such as medicine and healthcare. In the future, Yangpu will further strengthen basic research and promote the integration of industries and education, will further focus on the needs of industry chain building, and promote the agglomerative development of the pharmaceutical and medical industries in Yangpu, and will further strengthen policy support, provide quality services, provide all-round support for companies to develop markets and keep ahead in the forefront of industries, and create a situation of win-win development that features disciplinary progress, corporate development, industrial upgrading and public benefit.